Page 373 - Avian Virology: Current Research and Future Trends
P. 373

364  |  Lupiani et al.
          Witter, R.L., Nazerian, K., Purchase, H.G., and Burgoyne, G.H. (1970).   Yamauchi, Y., Daikoku, T., Goshima, F., and Nishiyama, Y. (2003). Herpes
            Isolation from turkeys of a cell-associated herpesvirus antigenically   simplex virus UL14 protein blocks apoptosis. Microbiol. Immunol. 47,
            related to Marek’s disease virus. Am. J. Vet. Res. 31, 525-538.  685–689.
          Witter, R.L., Lee, L.F., and Fadly, A.M. (1995). Characteristics of CVI988/  Yao, Y., Bassett, A., and Nair, V. (2016). Targeted editing of avian herpesvirus
            Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek’s   vaccine vector using crispr/cas9 nucleases. Int. J. Vaccines Technol. 1.
            disease virus. Avian Dis. 39, 269–284.              Young, L.S., and Murray, P.G. (2003). Epstein-Barr virus and oncogenesis:
          Witter, R.L., Li, D., Jones, D., Lee, L.F., and Kung, H.J. (1997). Retroviral   from latent genes to tumours. Oncogene 22, 5108–5121. https://doi.
            insertional mutagenesis of a herpesvirus: a Marek’s disease virus mutant   org/10.1038/sj.onc.1206556.
            attenuated for oncogenicity but not for immunosuppression or in vivo   Zelnik, V. (2004). Diagnosis of Marek’s disease. In Marek’s Disease: An
            replication. Avian Dis. 41, 407–421.                   Evolving Problem, Davison, F. and Nair, V., eds (Elsevier Ltd, London),
          Wu, P., Reed, W.M., and Lee, L.F. (2001). Glycoproteins H and L of Marek’s   pp. 156–167.
            disease virus form a hetero-oligomer essential for translocation and cell   Zhang, Y., Tang, N., Sadigh, Y., Baigent, S., Shen, Z., Nair, V., and Yao, Y.
            surface expression. Arch. Virol. 146, 983–992.         (2018). Application of CRISPR/Cas9 gene editing system on MDV-1
          Wu, T.F., Sun, W., Boussaha, M., Southwick, R., and Coussens, P.M. (1996).   Genome for the Study of Gene Function. Viruses 10, E279.
            Cloning and sequence analysis of a Marek’s disease virus origin binding   Zhang, Z., Ma, C., Zhao, P., Duan, L., Chen, W., Zhang, F., and Cui, Z.
            protein (OBP) reveals strict conservation of structural motifs among   (2014). Construction of recombinant Marek’s disease virus (rMDV)
            OBPs of divergent alphaherpesviruses. Virus Genes 13, 143–157.  co-expressing AIV-H9N2-NA and NDV-F genes under control of MDV’s
          Wu, T.F., Chen, H.H., and Wu, H. (2001). Functional characterization of   own bi-directional promoter. PLOS ONE 9, e90677.
            Marek’s disease virus (MDV) origin-binding protein (OBP): analysis of   Zhao, Y., Xu, H., Yao, Y., Smith, L.P., Kgosana, L., Green, J., Petherbridge,
            its origin-binding properties. Virus Genes 23, 227–239.  L., Baigent, S.J., and Nair, V. (2011). Critical role of the virus-encoded
          Xie, Q., Anderson, A.S., and Morgan, R.W. (1996). Marek’s disease virus   microRNA-155 ortholog in the induction of Marek’s disease
            (MDV) ICP4, pp38, and meq genes are involved in the maintenance of   lymphomas. PLOS Pathog.  7, e1001305.  https://doi.org/10.1371/
            transformation of MDCC-MSB1 MDV-transformed lymphoblastoid   journal.ppat.1001305.
            cells. J. Virol. 70, 1125–1131.                     Zhu, L.A., and Weller, S.K. (1992a). The six conserved helicase motifs of
          Xu, H., Yao, Y., Zhao, Y., Smith, L.P., Baigent, S.J., and Nair, V. (2008). Analysis   the UL5 gene product, a component of the herpes simplex virus type 1
            of the expression profiles of Marek’s disease virus-encoded microRNAs   helicase-primase, are essential for its function. J. Virol. 66, 469–479.
            by real-time quantitative PCR. J. Virol. Methods 149, 201–208. https://  Zhu, L.A., and Weller, S.K. (1992b). The UL5 gene of herpes simplex virus
            doi.org/10.1016/j.jviromet.2008.02.005.                type 1: isolation of a lacZ insertion mutant and association of the UL5
                                                                   gene product with other members of the helicase-primase complex. J.
                                                                   Virol. 66, 458–468.
   368   369   370   371   372   373   374   375   376   377   378